Carotid Disease & Stroke
DENVER – Meta-analysis shows 55% fewer disabling strokes with the left atrial appendage closure device, compared with warfarin.
Health agencies should take their cues from randomized clinical trial designs to avoid unintended consequences.
Tips & Tricks
Stent-graft coverage of the left subclavian artery (LSA) is often performed during TEVAR treatment of thoracic aortic pathologies and,...
To embolize or not to embolize ... that is the question when it comes to the management of carotid body tumors. Carotid body tumors (CBTs) are...
ANAHEIM, CALIF. – Dabigatran protected against thromboembolic events with less bleeding regardless of stent type, type of concomitant treatment,...
DENVER – SENIOR trial results spell end of the line for BMS.
The guidelines include strong recommendation for using a team-based approach for managing hypertension.
DENVER – ORBITA trial fails to show stenting benefit over optimal medical therapy in stable angina, but reactions to results are overblown.
DENVER – The analysis concludes TAVR costs less and improves quality-adjusted life-years more.
Top outcomes in landmark trial came with achieved SBP of 130-140 mm Hg.